---
annotations:
- type: Pathway Ontology
  value: signaling pathway pertinent to immunity
authors:
- MaintBot
- MartijnVanIersel
- ReactomeTeam
- Anwesha
- Wpblocked
- AlexanderPico
- Eweitz
description: A number of receptors and cell adhesion molecules play a key role in
  modifying the response of cells of lymphoid origin (such as B-, T- and NK cells)
  to self and tumor antigens, as well as to pathogenic organisms.<p><p>Molecules such
  as KIRs and LILRs form part of a crucial surveillance system that looks out for
  any derangement, usually caused by cancer or viral infection, in MHC Class I presentation.
  Somatic cells are also able to report internal functional impairment by displaying
  surface stress markers such as MICA. The presence of these molecules on somatic
  cells is picked up by C-lectin NK immune receptors.<p><p>Lymphoid cells are able
  to regulate their location and movement in accordance to their state of activation,
  and home in on tissues expressing the appropriate complementary ligands. For example,
  lymphoid cells may fine tune the presence and concentration of adhesion molecules
  belonging to the IgSF, Selectin and Integrin class that interact with a number of
  vascular markers of inflammation.<p><p>Furthermore, there are a number of avenues
  through which lymphoid cells may interact with antigen. This may be presented directly
  to a specific T-cell receptor in the context of an MHC molecule. Antigen-antibody
  complexes may anchor to the cell via a small number of lymphoid-specific Fc receptors
  that may, in turn, influence cell function further. Activated complement factor
  C3d binds to both antigen and to cell surface receptor CD21. In such cases, the
  far-reaching influence of CD19 on B-lymphocyte function is tempered by its interaction
  with CD21.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=198933
  Reactome].
last-edited: 2021-05-22
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1829
- /instance/WP1829
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1829.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: A number of receptors and cell adhesion molecules play a key role in
    modifying the response of cells of lymphoid origin (such as B-, T- and NK cells)
    to self and tumor antigens, as well as to pathogenic organisms.<p><p>Molecules
    such as KIRs and LILRs form part of a crucial surveillance system that looks out
    for any derangement, usually caused by cancer or viral infection, in MHC Class
    I presentation. Somatic cells are also able to report internal functional impairment
    by displaying surface stress markers such as MICA. The presence of these molecules
    on somatic cells is picked up by C-lectin NK immune receptors.<p><p>Lymphoid cells
    are able to regulate their location and movement in accordance to their state
    of activation, and home in on tissues expressing the appropriate complementary
    ligands. For example, lymphoid cells may fine tune the presence and concentration
    of adhesion molecules belonging to the IgSF, Selectin and Integrin class that
    interact with a number of vascular markers of inflammation.<p><p>Furthermore,
    there are a number of avenues through which lymphoid cells may interact with antigen.
    This may be presented directly to a specific T-cell receptor in the context of
    an MHC molecule. Antigen-antibody complexes may anchor to the cell via a small
    number of lymphoid-specific Fc receptors that may, in turn, influence cell function
    further. Activated complement factor C3d binds to both antigen and to cell surface
    receptor CD21. In such cases, the far-reaching influence of CD19 on B-lymphocyte
    function is tempered by its interaction with CD21.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=198933
    Reactome].
  keywords:
  - DAP10
  - SLAMF6 dimer
  - 'CD226 '
  - 'KLRD1 '
  - 'CD81 '
  - 'TRAV19 '
  - SLAMF6:SLAMF6:SAP,EAT2
  - 'Ig heavy chain V-III region KOL '
  - 'GMM '
  - 'Ig kappa chain V-II region FR '
  - CD200 bound to
  - 'Antigen '
  - 'HLA class I histocompatibility antigen, Cw-16 alpha chain '
  - 'Ig kappa chain V-I region DEE '
  - 'ULBP1 '
  - 'Ig kappa chain V-I region Gal '
  - 'IGLV3-12(1-?) '
  - 'Sialic acid '
  - Antibody
  - 'SLAMF7 '
  - 'CD200 '
  - I,III
  - LILRs
  - HLA-C Cw4 (group 2)
  - 'KIR2DL2 '
  - Antigen peptide
  - 'IGLV4-69(1-?) '
  - 'PVRL2 '
  - 'IGLV2-33(1-?) '
  - LAIR1
  - ICAM 1-5
  - 'LILRB5 '
  - 'KLRB1 '
  - 'KIR2DL1 '
  - integrin
  - 'Ig kappa chain V-II region Cum '
  - dimer:Hemagglutinin
  - 'Ig heavy chain V-II region NEWM '
  - interacting with
  - 'KIR3DL2 '
  - CXADR bound to JAML
  - lipid:TCR
  - 'CD22 '
  - 'C16 sulfatide '
  - 'CLEC2B '
  - CD200
  - 'ITGA4 '
  - L-selectin
  - 'IGLV7-46(1-?) '
  - 'class I MHC B56 '
  - 'Ig kappa chain V-I region AU '
  - 'class I MHC B82 '
  - 'CERA '
  - PIANP,NPDC1,CLEC4G,COLEC12 trimer
  - 'class I MHC B54 '
  - 'Ig lambda chain V-II region MGC '
  - 'KIR3DL1 '
  - 'KIR2DS1 '
  - 'ICAM3 '
  - known ligands
  - 'HCST '
  - KLRF1 dimer
  - CXADR
  - KLRF1 dimer:CLEC2B
  - alpha4beta1:VCAM1
  - 'CD99 '
  - KIR2DS2 complexed
  - 'TRBC1 '
  - lipid
  - KLRB1 dimer
  - 'class I MHC B58 '
  - 'SIGLEC5 '
  - with KIR3DL2
  - PVRL2
  - 'Ig heavy chain V-II region ARH-77 '
  - 'CD8A '
  - CD40:CD40L trimer
  - 'HLA class I histocompatibility antigen, alpha chain G precursor '
  - 'LILRA6 '
  - 'Ig kappa chain V-I region Daudi '
  - 'IGLC6 '
  - 'SIGLEC10 '
  - 'NCR3 '
  - 'ITGB7 '
  - 'IGLV2-18(1-?) '
  - 'class I MHC B39 '
  - 'class I MHC B15 '
  - 'HLA class I histocompatibility antigen, A-34 alpha chain '
  - 'class I MHC B73 '
  - 'IGKVA18(21-?) '
  - 'NPDC1 '
  - OSCAR:Collagen
  - 'CD3D '
  - 'Ig heavy chain V-II region WAH '
  - 'class I MHC B40 '
  - CMVPP65
  - 'HLA class I histocompatibility antigen, A-25 alpha chain '
  - 'class I MHC B8 '
  - CMVPP65:NCR3:FCRG3A:CD3Z dimer
  - 'Ig lambda chain V-II region TOG '
  - 'GalA-GSL '
  - 'HLA-H '
  - 'PILRA '
  - KIR2DL4
  - 'KIR2DS2 '
  - 'T-cell receptor alpha chain V region PY14 precursor '
  - LFA-1:ICAM 1-5
  - 'HLA class I histocompatibility antigen, A-1 alpha chain precursor '
  - NCR3LG1:NCR3:FCRG3A:CD3Z dimer
  - LILR-interacting MHC
  - 'LILRA3 '
  - CD200R1
  - 'CD160 '
  - 'Ig heavy chain V-I region HG3 '
  - NCR1:FCRG1A:CD3Z
  - Collagen types I,III
  - 'class I MHC B55 '
  - PVR
  - 'IGKV2-28 '
  - 'Ig lambda chain V-II region NEI '
  - 'HLA class I histocompatibility antigen, A-2 alpha chain '
  - SLAMF7 dimer
  - Fc-gamma receptors
  - 'HLA class I histocompatibility antigen, A-68 alpha chain '
  - 'CD19 '
  - 'HLA class I histocompatibility antigen, Cw-6 alpha chain precursor '
  - Ligand interacting
  - 'KLRK1 '
  - 'CD96 '
  - L-selectin ligands
  - 'KLRG1 '
  - 'Collagen types I,II,III '
  - 'CD3G '
  - 'TRAC '
  - with KIR3DL1
  - 'Ig lambda chain V-III region LOI '
  - 'ICAM1 '
  - 'TCRB '
  - 'IGKV2D-30 '
  - 'Glc-DAG-s2 '
  - 'Ig kappa chain V-III region VG '
  - OSCAR
  - 'HLA class I histocompatibility antigen, Cw-2 alpha chain '
  - HLA-Bw4
  - 'TYROBP '
  - Class I
  - 'class I MHC B42 '
  - 'HLA class I histocompatibility antigen, Cw-14 alpha chain '
  - NKG2D ligand
  - antigen-bearing MHC
  - T-cell receptor
  - 'Ig kappa chain V-III region POM '
  - 'HLA class I histocompatibility antigen, A-29 alpha chain '
  - Integrin
  - 'IGLV3-27(1-?) '
  - 'IGLC7 '
  - 'IGLV4-60(1-?) '
  - 'CD33 '
  - 'PG '
  - 'GalNAc-GD1a '
  - 'IGLV5-45(1-?) '
  - 'Ig lambda chain V-IV region Kern '
  - 'PVR '
  - 'class I MHC B13 '
  - 'Ig lambda chain V-I region HA '
  - CD226 bound to
  - SAP,EAT2
  - 'HN '
  - 'Ig heavy chain V-I region EU '
  - 'HLA class I histocompatibility antigen, B-48 alpha chain '
  - KIR2DL2/3
  - SELL
  - 'class I MHC B67 '
  - 'IGLV3-25(1-?) '
  - 'HLA class I histocompatibility antigen, A-26 alpha chain '
  - 'class I MHC B47 '
  - 'class I MHC B35 '
  - 'SIGLEC1 '
  - bound class I MHC
  - KIR3DL1
  - with NKG2D
  - 'MHC Class I '
  - lymphoid Fc gamma
  - 'IGLV3-16(1-?) '
  - 'SIGLEC9 '
  - VCAM1
  - 'LILRA1 '
  - MADCAM1-1
  - 'HLA class I histocompatibility antigen, A-69 alpha chain '
  - 'HLA class I histocompatibility antigen, Cw-12 alpha chain '
  - CLEC2B dimer
  - 'LAIR2 '
  - CD226
  - HLA-C group 1
  - 'LILRA2 '
  - SLAMF7
  - HLA-C group 2
  - 'LILRB2 '
  - HLA-E
  - HLA-E interacting
  - PILRA,PILRB
  - CD99
  - 'class I MHC B7 '
  - 'CD300 '
  - 'HLA class I histocompatibility antigen, Cw-15 alpha chain '
  - 'Ig heavy chain V-III region TRO '
  - CD21
  - 'alpha-mycolic acid '
  - HLA-C Cw3 (group 1)
  - 'ITGB2 '
  - 'HLA class I histocompatibility antigen, A-31 alpha chain '
  - Collagen type XVII
  - 'IGLV10-54(1-?) '
  - CD96:PVR
  - HLA-G interacting
  - KIR2DS1
  - 'class I MHC B18 '
  - TREM, CD300
  - 'HLA class I histocompatibility antigen, A-66 alpha chain '
  - 'HLA class I histocompatibility antigen, A-36 alpha chain '
  - 'class I MHC B53 '
  - PILRA:PIANP,NPDC1,CLEC4G,COLEC12 trimer
  - 'LAM '
  - 'Ig lambda chain V-I region VOR '
  - CD1:B2M:self-lipid
  - 'SIGLEC8 '
  - 'LILRB4 '
  - 'CD34-1 '
  - CERA,PE,PS
  - 'IGLV11-55(1-?) '
  - 'IGLV1-36(1-?) '
  - HLA-A3
  - 'RAET1E '
  - 'Ig heavy chain V-III region JON '
  - Integrin alpha4beta7
  - molecules
  - 'CLEC4G '
  - 'CD1D '
  - 'ICAM4 '
  - KLRD1
  - 'class I MHC B50 '
  - 'IGHV(1-?) '
  - 'PILRB '
  - LAIR2
  - AMICA1
  - 'SLAMF6 '
  - 'Ig lambda chain V-III region SH '
  - 'KLRF1 '
  - 'HLA class I histocompatibility antigen, A-43 alpha chain '
  - 'CD247-1 '
  - 'cd21(1-?) '
  - 'Ig lambda chain V-I region NEWM '
  - LAIR1:Collagen type
  - HLA-G
  - 'CRTAM '
  - 'IGHV7-81(1-?) '
  - 'class I MHC B44 '
  - 'SFTPD oligomer '
  - CD96
  - antigen
  - Complex of CD19,
  - 'AMICA1 '
  - 'IGLC3 '
  - 'HLA class I histocompatibility antigen, A-32 alpha chain '
  - 'IGLV4-3(1-?) '
  - 'CD1A '
  - CDH1(155-882)
  - 'CDH1(155-882) '
  - KIR3DL2
  - 'class I MHC B37 '
  - 'Ig heavy chain V-III region DOB '
  - 'KIR2DL4 '
  - 'PE '
  - NCR3LG1
  - 'Ig kappa chain V-I region BAN '
  - 'HLA class I histocompatibility antigen, Cw-5 alpha chain precursor '
  - KIR2DS2
  - 'class I MHC B45 '
  - 'IGKV3D-20 '
  - 'ITGB1 '
  - 'GM1 '
  - 'SIGLEC6 '
  - 'LAIR1 '
  - XVII
  - CD21 with C3d-bound
  - 'CXADR '
  - 'SIGLEC12 '
  - 'class I MHC B81 '
  - 'Collagen type III fibril '
  - CD200R
  - 'ICAM5 '
  - 'class I MHC B41 '
  - 'class I MHC B49 '
  - 'IGLC2 '
  - 'IGLV1-40(1-?) '
  - 'CD3E '
  - 'class I MHC B59 '
  - 'PIANP '
  - 'HLA class I histocompatibility antigen, alpha chain F precursor '
  - 'KIR2DL3 '
  - 'LILRA4 '
  - 'Ig kappa chain V-I region HK101 '
  - 'HLA class I histocompatibility antigen, Cw-3 alpha chain precursor '
  - 'Ig lambda chain V-IV region Bau '
  - antibody bound to
  - 'Ig heavy chain V-III region BUT '
  - 'IGHV1-2 '
  - 'BbGL-2c '
  - PILRA
  - 'Ig heavy chain V-III region BRO '
  - 'Ig heavy chain V-II region OU '
  - 'HLA class I histocompatibility antigen, A-30 alpha chain '
  - E-cadherin bound to
  - 'SH2D1A '
  - 'NCR3LG1 '
  - KIR2DL1
  - with KIR2DL4
  - 'CD40-1 '
  - 'FCGR3A '
  - C3d complexed with
  - complex
  - 'C3d fragment '
  - 'Ig lambda chain V-IV region Hil '
  - 'HLA class I histocompatibility antigen, A-3 alpha chain precursor '
  - 'IGLV(23-?) '
  - 'C30 mannosyl MPM '
  - 'IGLV3-22(1-?) '
  - 'VCAM1 '
  - CRTAM
  - 'HLA class I histocompatibility antigen, A-33 alpha chain '
  - 'Ig lambda chain V region 4A '
  - dimer
  - fibril
  - alpha4beta7:MADCAM1
  - 'KLRC1 '
  - 'HLA class I histocompatibility antigen, A-74 alpha chain '
  - Antigen-bound
  - 'HLA-C '
  - SIGLEC:sialic acid
  - LAIR2:Collagen type
  - KIR2DS1 complexed
  - 'GLYCAM1 '
  - 'COLEC12 '
  - 'Ig lambda chain V-I region NEW '
  - 'IGLV5-37(1-?) '
  - 'CD200R1 '
  - 'CMVPP65 '
  - 'TRBV12-3 '
  - receptors
  - MHC Class I
  - 'IgH  heavy chain V-III region VH26 precursor '
  - CRTAM bound to NECL2
  - 'NCR1 '
  - 'IGLC1 '
  - 'HLA class I histocompatibility antigen, A-24 alpha chain '
  - Sialic acid
  - 'CD40LG(1-261) '
  - 'HLA class I histocompatibility antigen, Cw-8 alpha chain '
  - 'DDM-838 '
  - CD160
  - 'IGKV4-1(21-?) '
  - Antigen-bound Ig G
  - 'Collagen type I fibril '
  - 'HLA class I histocompatibility antigen, Cw-4 alpha chain precursor '
  - group-I-interacting
  - NCR3:FCRG1A:CD3Z
  - 'Ig kappa chain V-I region AG '
  - 'class I MHC B46 '
  - 'ITGAL '
  - 'LILRB3 '
  - 'ICAM2 '
  - 'SELL '
  - 'PS '
  - 'ULBP3 '
  - 'class I MHC B27 '
  - NKG2D complexed with
  - 'Ig kappa chain V-II region RPMI 6410 '
  - 'HLA class I histocompatibility antigen, Cw-17 alpha chain '
  - CLEC2D dimer
  - CLEC2D dimer:KLRB1
  - CD1:B2M:self-lipid:TCR
  - with DAP12
  - 'PI '
  - 'squalene '
  - PILRA,PILRB:CD99
  - ITGA4:ITGB1
  - Class I molecules
  - 'SH2D1B '
  - I,II,III/SP-D
  - 'HA '
  - 'IGKV1-5(23-?) '
  - 'IGLV7-43(1-?) '
  - 'SIGLEC11 '
  - 'B2M(21-119) '
  - 'HLA class I histocompatibility antigen, Cw-18 alpha chain '
  - 'FCGR1A '
  - Hemagglutinin
  - CD81, CD225 and
  - 'Ig kappa chain V-III region B6 '
  - SIGLEC
  - Integrin alphaLbeta2
  - 'Ig heavy chain V-III region WEA '
  - 'FCGR2B '
  - 'IFITM1 '
  - 'IGKC '
  - Antigen
  - with KLRC1:KLRD1
  - Collagen types
  - 'class I MHC B38 '
  - CD40LG trimer
  - Lymphoid-expressed
  - 'Ig kappa chain V region EV15 '
  - 'HLA class I histocompatibility antigen, A-11 alpha chain '
  - 'IGLV8-61(1-?) '
  - 'IGLV2-11(1-?) '
  - SLAMF6
  - 'MADCAM1-1 '
  - 'OSCAR '
  - 'MICB '
  - 'HLA class I histocompatibility antigen, Cw-1 alpha chain '
  - 'Ig kappa chain V-I region Wes '
  - 'CD1C '
  - 'LILRB1 '
  - 'class I MHC B52 '
  - 'IGLV2-23(1-?) '
  - 'CLEC2D '
  - 'SIGLEC7 '
  - 'Ac2SGL '
  - 'class I MHC B14 '
  - 'class I MHC B51 '
  - 'TCRA '
  - CD226:PVR
  - KIRs
  - 'Ig lambda chain V-II region BOH '
  - 'TREMs '
  - 'HLA class I histocompatibility antigen, A-80 alpha chain '
  - 'IGKV1-12 '
  - CD1:B2M:microbial
  - 'CD1B '
  - TCR interacting with
  - KLRC1
  - 'IGLV1-44(1-?) '
  - Nectin 2
  - 'class I MHC B78 '
  - 'HLA class I histocompatibility antigen, A-23 alpha chain '
  - 'MICA '
  - HLA-C
  - 'HLA class I histocompatibility antigen, E alpha chain precursor '
  - 'Ig heavy chain V-II region MCE '
  - complex with CD8
  - LILR set
  - 'Collagen type XVII fibril '
  - 'Ig heavy chain V-III region CAM '
  - KLRG1
  - 'CD8B '
  - 'Ig lambda chain V-VI region AR '
  - 'LILRA5 '
  - TRIM, CD300:lipids
  - 'class I MHC B57 '
  - CD40 trimer
  - HLA Bw4 interacting
  - HLA-A3 interacting
  license: CC0
  name: Immunoregulatory interactions between lymphoid and non-lymphoid cells
seo: CreativeWork
title: Immunoregulatory interactions between lymphoid and non-lymphoid cells
wpid: WP1829
---